Tirzepatide
Appetite regulation & weight-management support
How it works
Tirzepatide is a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. It mimics two incretin hormones the gut releases after eating — hormones that signal satiety and enhance insulin secretion when blood glucose is elevated.
By activating both receptors, tirzepatide slows gastric emptying, reduces appetite, improves insulin sensitivity, and supports weight reduction. The dual mechanism is what distinguishes it from GLP-1-only agents.
What is known about the class
Tirzepatide has a plasma half-life of approximately five days, supporting once-weekly subcutaneous administration.
The class is known for gastrointestinal side effects — nausea, constipation, indigestion — that are most prominent during dose escalation and typically settle as the body adjusts. Slower titration under provider supervision reduces these effects.
Class-level information. Individual dose, schedule, and monitoring are set by the prescribing physician.
How this medication is regulated
The FDA has approved brand-name tirzepatide (Mounjaro, Zepbound) manufactured by Eli Lilly. The Meridian tirzepatide is a compounded formulation prepared by a licensed 503A compounding pharmacy under an individual prescription — a distinct product from the FDA-approved brand and not FDA-approved.
The FDA does not review compounded medications for safety, effectiveness, or manufacturing quality before they are marketed.
If a provider considers Tirzepatide for a member
A dual GIP/GLP-1 receptor agonist — a class of medications that supports appetite regulation, blood-sugar handling, and weight management by working with the body’s own incretin signaling. At Meridian it is provided as a prescription compounded formulation, prescribed only when a licensed physician determines it is appropriate for you.
A provider may evaluate tirzepatide when weight management, appetite regulation, metabolic health, or body-composition goals are central to an individual’s assessment — and when history, medications, and laboratory information support safe, supervised use.
A once-weekly subcutaneous injection, self-administered at home with training and guidance. Strength is individualized and typically adjusted gradually by the prescribing physician based on response and tolerance — no universal dose is published here.
What to know
- —This compounded formulation is not an FDA-approved drug; it is prepared by a licensed pharmacy under a physician’s prescription.
- —Digestive effects — nausea, constipation, or indigestion — are common, especially early, and usually settle as your physician adjusts the plan.
- —Not appropriate for everyone: personal or family history of medullary thyroid carcinoma or MEN 2, a history of pancreatitis, and pregnancy are among the factors your physician reviews carefully.
- —Lifestyle remains the foundation — your provider may recommend lifestyle optimization alone or another approach entirely.
- —A licensed physician independently decides whether tirzepatide is appropriate for you after reviewing your health information.
What’s new in Tirzepatide
Curated from public sources. Meridian does not endorse individual studies or news outlets; inclusion is not medical advice.
Nothing new yet — check back soon.
Every treatment option is presented for educational purposes only. All prescribing decisions are made independently by a licensed physician after review of your health history, goals, medications, laboratory information, and clinical evaluation. Nothing on this page is an offer of treatment or a guarantee of outcomes.
Meridian Vitality is a technology and health-services platform. Clinical services are provided by independent licensed medical professionals. Meridian Vitality does not independently diagnose, prescribe, or direct medical care.
Compounded medications are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or manufacturing quality before they are marketed. The availability of a treatment depends on the prescribing provider’s independent medical judgment, pharmacy availability, applicable law, the individual’s medical history, and other clinical considerations.
Potential benefits are not guaranteed. Individual results vary. Meridian Zenith™ is a proprietary Meridian Vitality program name for a compounded oxytocin / bremelanotide formulation.
Find out if Tirzepatide is appropriate for you.
A licensed physician independently reviews your intake and decides — you’re never charged unless care is approved.
Start Your Free Assessment